1/02/2020 *Updated twice a week*
Market Cap $15,800,000 *The Stock Market Watch*
Shares 8,316,875 *The Stock Market Watch*
Shares Held by Institutions 15.24% *Sounce CNN Business*
NDRA life Sciences Inc. Is engaged in commercialization of enhanced ultrasound
technology for the pre-clinical research market. The Company's Nexus 128 system
combines light-based thermoacoustics and unltrasound, to address the imaging needs
of researchers studying disease models in pre-clinical applications. The Company is
involved in developing Thermo Acoustic Enhanced Ultrasound (TAEUS) for incorporation
into new Ultrasound system. The (TAEUS) platform has capabilities and potential clinical
applications, such as enabling ultrasound to distinguish fat from lean tissue; enabling traditional
ultrasound to visualize changes in tissue temperature, in real time; enabling ultasound to view
blood vessels from any angle, uning only a saline solution contrasting agent, unlike Doppler
ultrasound which requires precise viewing angles, and enabling ultrsound to image blood
flow at the capillary level in a region, organ or tissue.
Price Targets
The 4 analysts offering 12-month price forecasts for NDRA Life Sciences Inc have a median target of $5.00 *CNN Business*